| For: | Lulic I, Lulic D, Pavicic Saric J, Bacak Kocman I, Rogic D. Personalized translational medicine: Investigating YKL-40 as early biomarker for clinical risk stratification in hepatocellular carcinoma recurrence post-liver transplantation. World J Transplant 2025; 15(2): 103036 [PMID: 40535496 DOI: 10.5500/wjt.v15.i2.103036] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v15/i2/103036.htm |
| Number | Citing Articles |
| 1 |
Jadranka Pavicic Saric, Dinka Lulic, Dunja Rogic, Stipislav Jadrijevic, Danko Mikulic, Tajana Filipec Kanizaj, Nikola Prpic, Laura Karla Bozic, Ivona Adamovic, Iva Bacak Kocman, Zrinka Sarec, Gorjana Erceg, Mirta Adanic, Petra Ozegovic Zuljan, Filip Jadrijevic, Ileana Lulic. YKL-40 in Virus-Associated Liver Disease: A Translational Biomarker Linking Fibrosis, Hepatocarcinogenesis, and Liver Transplantation. International Journal of Molecular Sciences 2025; 26(19): 9584 doi: 10.3390/ijms26199584
|
| 2 |
Ileana Lulic, Dinka Lulic, Ivan Durekovic, Jadranka Pavicic Saric, Iva Bacak Kocman, Zrinka Sarec, Dunja Rogic. YKL-40: Revolutionizing cardiac risk prediction and therapy in liver transplantation. World Journal of Transplantation 2025; 15(4): 105621 doi: 10.5500/wjt.v15.i4.105621
|
